As use of GLP-1 therapies grows, new data shed light on the challenges of sustaining treatment over time

Specialty New drugs 3/18/2024 Lenmeldy™ (atidarsagene autotemcel) Lenmeldy is an autologous hematopoietic stem cell-based gene therapy by Orchard Therapeutics, which was FDA approved for the...

Prime to present seven studies and receive the 2024 JMCP Award for Excellence

Research on GLP-1 drugs, specialty therapies and more helps improve affordability in health care